+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biomarkers Market by Biomarker Source (Blood, Saliva, Tissue), Technology (Immunoassay, Mass Spectrometry, Polymerase Chain Reaction), Biomarker Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082615
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biomarkers market is undergoing significant evolution as advancements in diagnostic technologies, data analytics, and precision medicine rapidly shape how diseases are detected and managed. As organizations adapt to a dynamically shifting healthcare landscape, understanding the core drivers and challenges in biomarker adoption is vital for strategic decision-making.

Market Snapshot: Biomarkers Market Size and Growth

The biomarkers market grew from USD 59.69 billion in 2024 to USD 68.08 billion in 2025 and is forecast to reach USD 132.94 billion by 2030. The sector is expected to maintain strong momentum with a CAGR of 14.27%, fueled by widespread applications across therapeutic areas, increasing investment in molecular diagnostics, and robust collaborations among healthcare stakeholders.

Scope & Segmentation of the Biomarkers Market

This report provides an in-depth analysis of the biomarkers ecosystem, focusing on the latest advancements, regional trends, technology platforms, and competitive dynamics.

  • Biomarker Source: Blood (including plasma and serum), saliva, tissue, urine
  • Technology: Immunoassays (chemiluminescent, ELISA, lateral flow), mass spectrometry (gas and liquid chromatography, MALDI-TOF), polymerase chain reaction (digital, quantitative), and sequencing (next-generation, Sanger)
  • Biomarker Type: Cellular biomarkers, genetic (DNA and RNA), metabolomic, protein
  • Application: Clinical trials, diagnostics, drug discovery, personalized medicine
  • End User: Academic and research institutes, diagnostic laboratories, hospitals, pharmaceutical companies
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Gulf countries, South Africa, Nordic nations), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, Taiwan)
  • Companies Profiled: Abbott Laboratories, Bio-Rad Laboratories, APIS Assay Technologies, Augurex Life Sciences, Biocrates Life Sciences, Bioinfra, BioVision, EKF Diagnostics, F. Hoffmann-La Roche, Merck KGaA, PerkinElmer, Proteomedix, QIAGEN, Renalytix, Siemens Healthcare, Sino Biological, Thermo Fisher Scientific, Charles River Laboratories, Nightingale Health, BioAgilytix, BioStarks, Biofourmis, Alto Neuroscience, Personalis, Owkin, VivoSense, Elo Health, Owlstone Medical, Biognosys, Clarigent Corporation.

Key Takeaways for Senior Decision-Makers

  • Ongoing integration of digital health and real-world data analytics is amplifying the clinical and operational value of biomarker innovation within patient care pathways.
  • Collaborative public-private consortia are driving the standardization of assay validation and regulatory frameworks, supporting faster clinical adoption of novel biomarker solutions.
  • AI and machine learning are increasingly used for biomarker discovery and patient stratification, opening new possibilities for targeted therapeutics and companion diagnostics.
  • Companies with flexible supply chains and multi-technology capabilities are best positioned to navigate disruptions and capitalize on evolving reimbursement and regulatory trends.
  • Contract research and manufacturing organizations offering comprehensive biomarker services drive operational efficiency and scale for diagnostic developers and pharmaceutical manufacturers.

Tariff Impact: Addressing US Trade and Supply Chain Risks

New United States tariffs introduced in 2025 have created upward pressure on sourcing and manufacturing costs for essential reagents, consumables, and diagnostic kits within the biomarkers market. Many industry leaders are mitigating these risks by nearshoring production, consolidating supplier relationships, and diversifying global supply strategies. Operational adjustments such as enhanced inventory management and dual-sourcing are helping companies minimize disruptions and maintain delivery timelines.

Methodology & Data Sources

This report utilizes a rigorous methodology combining comprehensive desk research with structured interviews among key stakeholders across academia, biopharma, and diagnostics. Quantitative data are corroborated through multiple independent sources, while qualitative insights are refined through expert workshops and external peer review, ensuring robust and actionable market intelligence.

Why This Report Matters

  • Provides end-to-end visibility into the fast-evolving biomarker market, enabling strategic planning and risk management for decision-makers.
  • Delivers granular segment and regional perspectives, supporting effective investment, partnership, and commercialization strategies.
  • Equips organizations to respond proactively to regulatory, technological, and macroeconomic shifts impacting biomarker innovation and adoption.

Conclusion

Biomarkers are a catalyst for advancing personalized healthcare, accelerating innovation and transformation across clinical diagnostics and therapeutics. Decision-makers equipped with these insights can navigate complexity and identify pathways for sustained competitive advantage in the evolving biomarker landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of AI-driven multiomics biomarker discovery platforms enhances precision diagnostics
5.2. Emergence of liquid biopsy ctDNA assays receiving expanded regulatory approvals for early cancer screening
5.3. Integration of machine learning algorithms in immuno-oncology biomarker panels drives personalized therapies
5.4. Development of microbiome-derived biomarkers for noninvasive gastrointestinal disease monitoring and prognosis
5.5. Shift towards point-of-care smartphone-based biomarker assays enabling decentralized chronic disease management
5.6. Growth in proteomics-based biomarker validation to support targeted drug development and clinical trial enrichment
5.7. Increasing utilization of wearable biosensors for continuous real-time tracking of metabolic biomarker fluctuations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biomarkers Market, by Biomarker Source
8.1. Introduction
8.2. Blood
8.2.1. Plasma
8.2.2. Serum
8.3. Saliva
8.4. Tissue
8.5. Urine
9. Biomarkers Market, by Technology
9.1. Introduction
9.2. Immunoassay
9.2.1. Chemiluminescent Immunoassay
9.2.2. Elisa
9.2.3. Lateral Flow Assay
9.3. Mass Spectrometry
9.3.1. Gas Chromatography Mass Spectrometry
9.3.2. Liquid Chromatography Mass Spectrometry
9.3.3. Matrix Assisted Laser Desorption Ionization Time Of Flight
9.4. Polymerase Chain Reaction
9.4.1. Digital Polymerase Chain Reaction
9.4.2. Quantitative Polymerase Chain Reaction
9.5. Sequencing
9.5.1. Next Generation Sequencing
9.5.2. Sanger Sequencing
10. Biomarkers Market, by Biomarker Type
10.1. Introduction
10.2. Cellular Biomarkers
10.3. Genetic Biomarkers
10.3.1. DNA Biomarkers
10.3.2. RNA Biomarkers
10.4. Metabolomic Biomarkers
10.5. Protein Biomarkers
11. Biomarkers Market, by Application
11.1. Introduction
11.2. Clinical Trials
11.3. Diagnostics
11.4. Drug Discovery
11.5. Personalized Medicine
12. Biomarkers Market, by End User
12.1. Introduction
12.2. Academic And Research Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Pharmaceutical Companies
13. Americas Biomarkers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biomarkers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biomarkers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Bio-Rad Laboratories, Inc.
16.3.3. APIS Assay Technologies Limited
16.3.4. Augurex Life Sciences Corp
16.3.5. Biocrates Life Sciences AG
16.3.6. BIOINFRA Life Science Inc.
16.3.7. BioVision Inc.
16.3.8. EKF Diagnostics Holdings PLC
16.3.9. F. Hoffmann-La Roche, Ltd.
16.3.10. Merck KgaA
16.3.11. PerkinElmer, Inc.
16.3.12. Proteomedix AG
16.3.13. QIAGEN GmbH
16.3.14. Renalytix PLC
16.3.15. Siemens Healthcare GmbH
16.3.16. Sino Biological Inc.
16.3.17. Thermo Fisher Scientific, Inc.
16.3.18. Charles River Laboratories, Inc.
16.3.19. Nightingale Health Plc
16.3.20. BioAgilytix
16.3.21. BioStarks
16.3.22. Biofourmis Inc.
16.3.23. Alto Neuroscience,Inc.
16.3.24. Personalis, Inc.
16.3.25. Owkin Inc.
16.3.26. VivoSense, Inc.
16.3.27. Elo Health, Inc.
16.3.28. Owlstone Medical Limited
16.3.29. Biognosys AG
16.3.30. Clarigent Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIOMARKERS MARKET: RESEARCHAI
FIGURE 26. BIOMARKERS MARKET: RESEARCHSTATISTICS
FIGURE 27. BIOMARKERS MARKET: RESEARCHCONTACTS
FIGURE 28. BIOMARKERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOMARKERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMARKERS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOMARKERS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMARKERS MARKET SIZE, BY GAS CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOMARKERS MARKET SIZE, BY GAS CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMARKERS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOMARKERS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMARKERS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOMARKERS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOMARKERS MARKET SIZE, BY DNA BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOMARKERS MARKET SIZE, BY DNA BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOMARKERS MARKET SIZE, BY RNA BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOMARKERS MARKET SIZE, BY RNA BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 148. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 149. CANADA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 150. CANADA BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 151. CANADA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. CANADA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. CANADA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 154. CANADA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 155. CANADA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 156. CANADA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 157. CANADA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 158. CANADA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 159. CANADA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 160. CANADA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 161. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 164. CANADA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 165. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. CANADA BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 291. GERMANY BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 294. GERMANY BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 295. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 298. GERMANY BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 299. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. GERMANY BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 307. FRANCE BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 312. FRANCE BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 313. FRANCE BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 316. FRANCE BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 317. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 318. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 319. FRANCE BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 320. FRANCE BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 321. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. FRANCE BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. FRANCE BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. ITALY BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2024 (USD MILLION)
TABLE 348. ITALY BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025-2030 (USD MILLION)
TABLE 349. ITALY BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 350. ITALY BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 351. ITALY BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 352. ITALY BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 353. ITALY BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 354. ITALY BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 355. ITALY BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 356. ITALY BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 357. ITALY BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 358. ITALY BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 359. ITALY BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 360. ITALY BIOMARKERS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 361. ITALY BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 362. ITALY BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 363. ITALY BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 364. ITALY BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 365. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 366. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 367. ITALY BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • APIS Assay Technologies Limited
  • Augurex Life Sciences Corp
  • Biocrates Life Sciences AG
  • BIOINFRA Life Science Inc.
  • BioVision Inc.
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche, Ltd.
  • Merck KgaA
  • PerkinElmer, Inc.
  • Proteomedix AG
  • QIAGEN GmbH
  • Renalytix PLC
  • Siemens Healthcare GmbH
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories, Inc.
  • Nightingale Health Plc
  • BioAgilytix
  • BioStarks
  • Biofourmis Inc.
  • Alto Neuroscience,Inc.
  • Personalis, Inc.
  • Owkin Inc.
  • VivoSense, Inc.
  • Elo Health, Inc.
  • Owlstone Medical Limited
  • Biognosys AG
  • Clarigent Corporation

Table Information